Frontlight ResearchEarly access
Taking people in United StatesNo phase
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
Key facts
- Who runs it
- Johns Hopkins University
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- Oct 2003
- Expected to end
- Jul 2029
- Type of study
- Observational
- Record updated
- 14 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Left ventricular ejection fraction <or = 35%
- Planned implantable cardioverter-defibrillator (ICD) implantation for clinical indications (primary prevention)
Who cannot take part
- Contraindication to undergoing MRI (metallic implant, pacemaker, etc.)
- History of sudden death (secondary prevention)
Where in United States
- Johns Hopkins Medical InstitutionsBaltimore, United StatesContact: Tricia Steinberg, RNTaking people
About the trial
What the trial wants to find out
Sudden cardiac death is a tragic event that strikes all age groups and is unfortunately increasing in prevalence. Because it is difficult to predict those at highest risk, this study is designed to test the hypothesis that new imaging techniques (magnetic resonance imaging [MRI] and computed tomography [CT]) are useful for identifying factors which put people at high risk for sudden death.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Functional Energetics and Imaging for Phenotypic Characterization of Patients at Risk for Sudden Cardiac Death
- Publications
- Record updated
- 14 January 2026